Innovative Eyewear (LUCY) Competitors $1.98 -0.32 (-13.91%) Closing price 04/4/2025 03:58 PM EasternExtended Trading$2.06 +0.08 (+3.79%) As of 04/4/2025 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock LUCY vs. NMTC, DRIO, COCH, PYPD, MDAI, SURG, PTHL, RVP, VVOS, and NXGLShould you be buying Innovative Eyewear stock or one of its competitors? The main competitors of Innovative Eyewear include NeuroOne Medical Technologies (NMTC), DarioHealth (DRIO), Envoy Medical (COCH), PolyPid (PYPD), Spectral AI (MDAI), SurgePays (SURG), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), Retractable Technologies (RVP), Vivos Therapeutics (VVOS), and NEXGEL (NXGL). These companies are all part of the "medical equipment" industry. Innovative Eyewear vs. NeuroOne Medical Technologies DarioHealth Envoy Medical PolyPid Spectral AI SurgePays Pheton Holdings Ltd Class A Ordinary Shares Retractable Technologies Vivos Therapeutics NEXGEL NeuroOne Medical Technologies (NASDAQ:NMTC) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, community ranking, valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and media sentiment. Does the MarketBeat Community favor NMTC or LUCY? NeuroOne Medical Technologies received 61 more outperform votes than Innovative Eyewear when rated by MarketBeat users. However, 100.00% of users gave Innovative Eyewear an outperform vote while only 71.59% of users gave NeuroOne Medical Technologies an outperform vote. CompanyUnderperformOutperformNeuroOne Medical TechnologiesOutperform Votes6371.59% Underperform Votes2528.41% Innovative EyewearOutperform Votes2100.00% Underperform VotesNo Votes Is NMTC or LUCY more profitable? NeuroOne Medical Technologies has a net margin of -82.17% compared to Innovative Eyewear's net margin of -514.01%. Innovative Eyewear's return on equity of -115.86% beat NeuroOne Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets NeuroOne Medical Technologies-82.17% -270.70% -129.70% Innovative Eyewear -514.01%-115.86%-105.40% Do insiders & institutionals hold more shares of NMTC or LUCY? 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are held by institutional investors. 8.9% of NeuroOne Medical Technologies shares are held by company insiders. Comparatively, 6.4% of Innovative Eyewear shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has better valuation and earnings, NMTC or LUCY? Innovative Eyewear has lower revenue, but higher earnings than NeuroOne Medical Technologies. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroOne Medical Technologies$5.75M2.55-$12.32M-$0.26-1.83Innovative Eyewear$1.64M2.97-$6.66M-$6.27-0.32 Which has more volatility & risk, NMTC or LUCY? NeuroOne Medical Technologies has a beta of 0.61, indicating that its stock price is 39% less volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 2.75, indicating that its stock price is 175% more volatile than the S&P 500. Does the media prefer NMTC or LUCY? In the previous week, NeuroOne Medical Technologies had 6 more articles in the media than Innovative Eyewear. MarketBeat recorded 6 mentions for NeuroOne Medical Technologies and 0 mentions for Innovative Eyewear. NeuroOne Medical Technologies' average media sentiment score of 0.00 equaled Innovative Eyewear'saverage media sentiment score. Company Overall Sentiment NeuroOne Medical Technologies Neutral Innovative Eyewear Neutral SummaryNeuroOne Medical Technologies and Innovative Eyewear tied by winning 7 of the 14 factors compared between the two stocks. Remove Ads Get Innovative Eyewear News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LUCY vs. The Competition Export to ExcelMetricInnovative EyewearOphthalmic goods IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.86M$10.16B$5.26B$7.12BDividend YieldN/A0.96%4.89%4.08%P/E Ratio-0.2032.6521.3817.50Price / Sales2.972.69355.0689.08Price / CashN/A14.5338.1834.64Price / Book0.232.296.233.79Net Income-$6.66M$224.27M$3.21B$247.48M7 Day Performance-27.74%-15.97%-8.47%-6.79%1 Month Performance-52.17%-21.93%-4.87%-11.53%1 Year Performance-66.01%-31.12%2.54%-7.82% Innovative Eyewear Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LUCYInnovative EyewearN/A$1.98-13.9%N/A-66.0%$4.86M$1.64M-0.209Gap DownNMTCNeuroOne Medical Technologies0.2992 of 5 stars$0.97-5.8%N/A-61.7%$29.94M$5.75M-3.7320News CoverageDRIODarioHealth1.7431 of 5 stars$0.70+1.7%$1.50+114.3%-58.5%$29.10M$27.04M-0.74200COCHEnvoy Medical1.937 of 5 stars$1.42-1.0%$8.00+465.4%-77.7%$28.65M$278,000.000.0034Earnings ReportUpcoming EarningsAnalyst RevisionNews CoveragePositive NewsGap UpPYPDPolyPid2.1655 of 5 stars$2.94+4.4%$11.33+286.1%-47.7%$28.64MN/A-0.5980MDAISpectral AI2.9133 of 5 stars$1.49-12.4%$4.75+218.8%-49.2%$27.70M$27.26M-2.2983Analyst ForecastShort Interest ↓Analyst RevisionGap DownHigh Trading VolumeSURGSurgePays2.8084 of 5 stars$1.31-2.2%$8.50+548.9%-40.7%$26.41M$83.60M-1.1640Gap DownPTHLPheton Holdings Ltd Class A Ordinary SharesN/A$3.91-7.8%N/AN/A$25.74M$572,291.000.0011Positive NewsGap UpRVPRetractable TechnologiesN/A$0.75+0.4%N/A-37.0%$22.55M$38.27M-1.39240Analyst ForecastPositive NewsGap DownVVOSVivos Therapeutics2.3742 of 5 stars$3.71+3.1%$6.30+69.8%-15.3%$21.85M$14.58M-0.65160NXGLNEXGEL0.6237 of 5 stars$3.09+14.4%N/A+19.5%$20.98M$6.73M-5.3310Upcoming EarningsGap Down Remove Ads Related Companies and Tools Related Companies NMTC Competitors DRIO Competitors COCH Competitors PYPD Competitors MDAI Competitors SURG Competitors PTHL Competitors RVP Competitors VVOS Competitors NXGL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LUCY) was last updated on 4/6/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThinking of buying Nvidia? Read this firstI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovative Eyewear, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovative Eyewear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.